Few supplements prompt as many pharmacy counter questions as vitamin B12. Tiredness, tingling fingers, vegan diets, and the occasional TikTok trend all send people to the shelves looking for cobalamin. Most of them do not need it — but the ones who do can be helped a great deal.

This is a pharmacy-counter guide to what the evidence actually says in 2026: which form to pick, when oral is enough, when an injection is the only option, and when the right answer is to send the patient to their GP for a blood test rather than sell anything at all.

Who actually benefits from supplementing B12

Most UK adults get enough vitamin B12 from meat, fish, eggs and dairy. The NHS recommendation for adults is 1.5 micrograms per day. A typical Western diet supplies several times that.

The people who genuinely benefit from supplementation fall into a handful of groups:

• Strict vegans and long-term vegetarians who do not use fortified foods or nutritional yeast.
• Adults over 60, because up to 20% show reduced gastric acid and intrinsic factor production with age, limiting absorption from food-bound B12.
• Patients on long-term proton-pump inhibitors or metformin, both of which modestly reduce B12 absorption.
• People with pernicious anaemia, atrophic gastritis, coeliac disease, Crohn's or a history of gastric or ileal surgery, where absorption is impaired at a mechanism level.
• Patients with laboratory-confirmed B12 deficiency identified by their GP.

For everyone else — young, well, meat-eating, no symptoms — the clinical benefit of supplementation is not supported by evidence.

Cyanocobalamin vs methylcobalamin: does the form matter?

The three forms found on UK pharmacy shelves are cyanocobalamin, methylcobalamin and, less commonly, adenosylcobalamin. A fourth, hydroxocobalamin, is the injectable form used by the NHS.

Cyanocobalamin is the cheapest and most widely available. In the body it is converted into the two active coenzyme forms — methylcobalamin and adenosylcobalamin — as needed. The marketing claim that methylcobalamin is "bioavailable" and cyanocobalamin is not is not supported by head-to-head studies in typical deficiency. Both raise serum B12 and correct anaemia.

Methylcobalamin may have a theoretical advantage in patients with specific metabolic or genetic inability to convert cyanocobalamin efficiently, but these are rare and typically managed in secondary care. For general counter advice, the guidance from NICE Clinical Knowledge Summaries is that oral cyanocobalamin at a high enough dose is adequate for dietary deficiency.

Oral vs sublingual vs injection

The classic teaching is that B12 deficiency requires intramuscular hydroxocobalamin because oral absorption depends on intrinsic factor. That teaching has been updated.

At high oral doses (1,000–2,000 mcg daily), about 1% of the dose is absorbed by passive diffusion — intrinsic factor is not required. Randomised trials in adults with dietary deficiency have shown that this passive route can correct serum B12 and even haematological indices without injection.

Sublingual preparations are absorbed similarly to swallowed oral — there is no robust evidence that keeping the tablet under the tongue meaningfully improves delivery over chewing and swallowing.

Injection remains the first-line treatment where:

• B12 deficiency causes neurological symptoms (peripheral neuropathy, subacute combined degeneration of the cord), where rapid repletion is critical.
• The patient cannot absorb oral B12 at all — typically pernicious anaemia or after ileal resection.
• Compliance with daily high-dose oral is not realistic.

Pharmacies do not initiate injectable B12. Patients asking about injection should be redirected to their GP for diagnosis.

What to say across the counter

The question behind "can I have a B12 supplement?" is often "am I tired for a reason that a vitamin can fix?" Fatigue has many more common causes than B12 deficiency — sleep, stress, iron deficiency, hypothyroidism, low mood. Selling a supplement to a fatigued adult with no risk factor is unlikely to help them and may delay a proper diagnosis.

A structured counter conversation covers:

1. Diet — are animal products in the picture, or are they not?
2. Age and medications — over 60, on metformin or a PPI?
3. Symptoms beyond tiredness — tingling in the hands or feet, memory changes, glossitis?
4. Previous investigation — has a GP checked B12, ferritin and thyroid function in the last year?

If the answer to (3) is yes, the supplement aisle is the wrong destination. That patient needs a blood test, not a box of tablets. The NICE CKS summary on B12 and folate deficiency anaemia is explicit that investigation should precede treatment in symptomatic patients.

Safety and interactions

Vitamin B12 has no established upper tolerable intake in the UK. Very high oral doses (1–2 mg daily) are considered safe for most adults, with no routine upper limit set by EFSA or SACN.

A handful of points are worth flagging:

• Pregnancy and breastfeeding — routine supplementation is safe, and B12 requirements rise modestly in pregnancy. Vegan women in particular should supplement.
• Metformin — long-term metformin reduces B12 absorption. Current NICE guidance supports periodic B12 measurement in patients on metformin with risk factors or symptoms.
• Before blood tests — supplementation normalises serum B12 quickly and can mask a true deficiency. If a patient is on the way to a GP test, advise them to finish their course of investigation before self-treating.

When the pharmacist should refuse the sale

Supplements are not a harmless default. The counter refusal rules familiar from when a pharmacist refuses to supply apply here too: if a patient presents with neurological symptoms and is asking for self-treatment, the right answer is to signpost to the GP, not dispense 1,000 mcg tablets for the next three months.

Further reading on PharmSee

• Magnesium supplements: types, uses and what the evidence shows
• Probiotics at the pharmacy: IBS, antibiotics and the evidence
• Vitamin D in UK adults: NHS guidance and pharmacy advice

Explore UK community pharmacies and services on PharmSee.

Sources and caveats

The guidance in this piece is drawn from NICE CKS, BNF, the NHS website and SACN nutrition statements at the time of writing. Individual clinical decisions — including whether to investigate or treat suspected deficiency — remain with the patient's GP or pharmacist prescriber. This article is general information for UK community pharmacy staff and the patients they advise, not personalised medical advice.